Pyrexia And Rash Flashcards
What is Henoch-Schnonlein purpurin (HSP)?
- Henoch-Schönlein purpura (HSP) is an IgA-mediated, autoimmune hypersensitivity vasculitis of childhood.
- The main clinical features are skin purpura, arthritis, abdominal pain, gastrointestinal bleeding, and nephritis. The aetiology remains unknown.
What is the epidemiology of HSP?
- HSP is a rare condition but is the most common form of systemic vasculitis in children; 90% of cases occur in childhood under the age of 10 years. The peak prevalence is in children aged 4-6 years.
- It is rare in infants and young children. It occasionally occurs in adolescents and adults, and tends to be more severe and more likely to cause long-term renal problems when it occurs in adults.
What is the aetiology of HSP?
• The condition tends to be seasonal and there is often a history of recent infection.
Infections preceding HSP include those involving group A streptococci, mycoplasma, Epstein-Barr virus, Coxsackievirus, hepatitis A and B, parvovirus B19, campylobacter, varicella and adenoviruses. Vaccination has also been described as a trigger.
- There is also an association with malignancy; usually solid tumours rather than haematological malignancies, and more common in adult males.
- IgA immune complexes are involved in the pathophysiology of HSP, depositing in the small blood vessels of the skin, joints, kidneys and gastrointestinal tract, causing an inflammatory reaction.
What is the presentation of HSP?
- The disease occurs mostly in the autumn or winter months. There may be a history of a preceding upper respiratory tract infection (URTI) or less commonly a gastrointestinal infection.
- Generally, patients appear to be mildly ill, with low-grade fever.
- There is a symmetrical, erythematous macular rash, especially on the back of the legs, buttocks and ulnar side of the arms.
- Within 24 hours, the macules evolve into purpuric lesions, which may coalesce and resemble bruises.
- Typically the purpura are slightly raised and palpable.
- Abdominal pain and bloody diarrhoea may precede the typical purpuric rash. HSP may also cause nausea and vomiting.
- Renal involvement
- Scrotal involvement may mimic testicular torsion.
- Headaches may occur, and occasionally seizures and other nonspecific neurological symptoms.
What is the renal involvement in HSP?
o Usually occurs within three months of disease onset.
o There is usually no relationship between the severity of nephritis and the extent of the other manifestations of HSP.
o Microscopic haematuria with mild-to-moderate proteinuria may occur.
o Nephrotic syndrome may also occur.
o Oliguria and hypertension are uncommon.
Which signs and symptoms are required before the diagnosis of HSP?
For a diagnosis of HSP there must be palpable purpura, which is not thrombocytopenic/petechiae, and one or more of the following:
o Diffuse abdominal pain.
o Typical histopathology (leukocytoclastic vasculitis or proliferative glomerulonephritis with predominant IgA deposits).
o Arthritis or arthralgia.
o Renal involvement (demonstrated by quantified proteinuria or haematuria).
What is the differential diagnosis of HSP?
- Intussusception
- SLE
- Thrombocytopenia
- Meningococcal meningitis
- Glomerulonephritis
- G.I symptoms such as IBD
What are the investigations for HSP?
- Diagnosis of HSP is clinical and not based on laboratory investigations, and there is no definitive test. The following tests may be relevant:
- Urinalysis (should always be performed): haematuria and/or proteinuria are present in 20-40% of patients.
- FBC: there may be raised white cell count with eosinophilia; normal or increased platelets. Helps in excluding other diagnoses such as thrombocytopenia.
- Raised ESR.
- Serum creatinine may be elevated in renal involvement.
- Serum IgA levels are often increased. This is not diagnostic.
- Autoantibody screen: connective tissue diseases.
- Abdominal ultrasound: if there are gastrointestinal symptoms - for diagnosis of intestinal obstruction.
- Barium enema: may be used to confirm and treat intussusception.
- Testicular ultrasound: assessment of possible torsion.
- Renal biopsy: if there is persistent nephrotic syndrome.
- Screening for cancer should be considered for older adults who develop HSP with no preceding infection
What is the management of HSP?
HSP is usually self-limiting and no form of therapy has been shown appreciably to shorten the duration of disease or prevent complications. Therefore, treatment for most patients remains primarily supportive and is entirely symptomatic unless there is renal involvement. This includes rehydration, pain relief, wound care for ulcerative lesions and treatment for intussusception where present.
Non-steroidal anti-inflammatory drugs (NSAIDs) may help joint pain but should be used with caution in patients with renal insufficiency or gastrointestinal symptoms.
Admission to hospital may be required in some cases for monitoring of abdominal and renal complications.
Corticosteroids can ameliorate associated arthralgia and the symptoms associated with gastrointestinal dysfunction, but it seems there is no place for routine use and no evidence of benefit of prednisone in preventing serious long-term kidney disease in HSP.
Plasma exchange is used in the management of some adults with vasculitis and idiopathic rapidly progressive nephritis but further trials are needed.
When is monitoring required in HSP?
GPs are likely to be involved in monitoring for renal involvement, usually under written guidance from the secondary care specialist.
Typical monitoring advice would be:
o For those with no proteinuria, blood pressure checking and urinalysis at days 7 and 14 and at 1, 3, 6 and 12 months.
o For those with proteinuria, follow-up at days 7 and 14, monthly from 1-6 months and then at 12 months.
What are the complications of HSP?
- Renal impairment
- MI
- Pulmonary haemorrhage
- GI bleeding
- Intussusception
- Bowel infarction
- Testicular torsion
- Seizures
What is immune thrombocytopenic purpura?
Immune thrombocytopenia (ITP) describes an autoimmune disorder in which the number of circulating platelets is reduced. This is due to their increased destruction, and sometimes also due to reduced production.
What is the aetiology of ITP?
In ITP, otherwise normal platelets are destroyed, most often in response to an unknown stimulus.
This may occur in isolation (primary ITP) or in association with other disorders (secondary).
What are the causes of secondary ITP?
o Other autoimmune disorders (including antiphospholipid antibody syndrome and systemic lupus erythematosus).
o Viral infections (including cytomegalovirus, varicella-zoster, hepatitis C and HIV).
o Infection with Helicobacter pylori.
o Medication.
o Lymphoproliferative disorders.
How does ITP present in children?
- ITP in children most commonly occurs following a viral infection, or occasionally following immunisation.
- It is usually a self-limiting disorder which follows a benign course and recovers spontaneously after 6-8 weeks.
- The clinical picture ranges from no symptoms whatsoever to life-threatening intracranial haemorrhage. Some children with ITP will have no symptoms at all.
- The most common presentation is petechiae or bruising. Up to a quarter present with nosebleeds. Haematuria and gastrointestinal bleeds are less common. Older girls may have menorrhagia. Intracranial bleeds occur very rarely.
What are the differentials of ITP?
o Aplastic anaemia o Leukaemia o Fanconi’s anaemia o VWD o NAI o TTP o DIC
What are the investigations for ITP in children?
o FBC
o Peripheral blood smear
o Bone marrow examination- only required if atypical features or diagnosis are in doubt
What is the management of ITP in children?
o Treatment is considered on the basis of clinical symptoms and not on the basis of platelet count alone, as children with severe thrombocytopenia are often asymptomatic and do not have a serious risk of a bleed.
o The majority of children with ITP do not need therapy and have a spontaneous resolution of the disease
o Any of the following may be used in a specialist setting if it is thought that the clinical condition requires that the platelet count should be raised:
o First-line treatment
Prednisolone.
Intravenous immunoglobulin.
Intravenous anti-D immunoglobulin (in rhesus-positive children).
o Second-line treatment for those resistant to first-line treatment and with significant bleeding
Rituximab.
High-dose dexamethasone.
o Other treatments
Tranexamic acid is used for menorrhagia, but is contra-indicated if there is haematuria.
Emergency platelet transfusions are sometimes used.
o Surgical
Splenectomy is rarely indicated in childhood ITP and is only used in the event of life-threatening bleeding, or in children with severe, chronic, unremitting ITP present for 12-24 months with severe symptoms.
What is the presentation of ITP in adults?
- Unlike ITP in children, adult ITP does not normally follow an infection and usually has an insidious onset. It is more likely to follow a chronic course in affected adults than in children.
- FBC and peripheral blood smear are the essential first-line tests. All those with ITP should be screened for HIV and hepatitis C, as treating the underlying cause may alter the disease course.